Galapagos NV
GLPG
#4563
Rank
$2.11 B
Marketcap
$31.59
Share price
-0.57%
Change (1 day)
17.22%
Change (1 year)

Galapagos NV (GLPG) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : $1.24 Billion USD

According to Galapagos NV's latest financial reports the company's total liabilities are $1.24 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Galapagos NV - Total liabilities on balance sheet (from 2008 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31$1.28 B-25.34%
2023-12-31$1.72 B-27.11%
2022-12-31$2.36 B-17.97%
2021-12-31$2.88 B-22.96%
2020-12-31$3.74 B4.79%
2019-12-31$3.57 B1288.09%
2018-12-31$0.25 B-21.7%
2017-12-31$0.32 B-3.62%
2016-12-31$0.34 B302.89%
2015-12-31$84.75 M8.33%
2014-12-31$78.24 M-52.88%
2013-12-31$0.16 B7.4%
2012-12-31$0.15 B178.95%
2011-12-31$55.42 M-8.33%
2010-12-31$60.45 M21.15%
2009-12-31$49.9 M3.47%
2008-12-31$48.23 M-34.06%
2007-12-31$73.14 M-4.59%
2006-12-31$76.66 M216.84%
2005-12-31$24.19 M240.04%
2004-12-31$7.11 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
AstraZeneca
AZN
$68.48 B 5,379.63%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
$113.53 B 8,984.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
$66.02 B 5,182.97%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
$136.49 B 10,821.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
$0.12 B-90.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
$32.91 B 2,533.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
$32.60 B 2,508.56%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
$61.28 B 4,803.50%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
$77.63 B 6,112.06%๐Ÿ‡บ๐Ÿ‡ธ USA